Vascular Neurology Research

ENROLLING STUDIES:

Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA)
https://www.nihstrokenet.org/captiva/home

https://clinicaltrials.gov/ct2/show/NCT05047172?term=Captiva&draw=2&rank=1

ICH survivors with AF to apixaban or aspirin (ASPIRE)
https://www.nihstrokenet.org/aspire-trial/home

https://clinicaltrials.gov/ct2/show/NCT03907046?term=Aspire&cond=AFib&draw=2&rank=2

A multicenter, randomized, placebo controlled, double-blind, parallel group and event driven Phase 3 study of the oral FXIa inhibitor asundexian (BAY 2433334) for the secondary prevention of ischemic stroke in adult patients with an acute non-cardioembolic ischemic stroke or high-risk TIA (OCEANIC)

https://clinicaltrials.gov/ct2/show/NCT05686070?term=oceanic&cond=stroke&draw=2&rank=2

Statins use in intracerebral hemorrhage patients (SATURN)
https://www.nihstrokenet.org/saturn-trial/home

https://clinicaltrials.gov/ct2/show/NCT03936361?term=saturn&cond=ICH+-+Intracerebral+Hemorrhage&draw=2&rank=1

Optimal Delay Time to Initiate Anticoagulation after Ischemic Stroke in Atrial Fibrillation (START)
https://lonestarstroke.com/start/

https://clinicaltrials.gov/ct2/show/NCT03021928?term=start&cond=AFib&draw=2&rank=4

Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on Recovery (DISCOVERY)
https://discoverystudy.org/

https://clinicaltrials.gov/ct2/show/NCT04916210?term=discovery&cond=stroke&draw=2&rank=1